Clinical Trial Update: Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating scalp cooling to prevent persistent hair loss after docetaxel in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia
• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Hospital San Carlos, Madrid | Conditions: Alopecia, Breast Cancer | Phase 2 | Status: COMPLETED